
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity
Nicola Tumino, Francesca Besi, Stefania Martini, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 36
Nicola Tumino, Francesca Besi, Stefania Martini, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Natural killer cells in antitumour adoptive cell immunotherapy
Tamara Laskowski, Alexander Biederstädt, Katayoun Rezvani
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 557-575
Open Access | Times Cited: 479
Tamara Laskowski, Alexander Biederstädt, Katayoun Rezvani
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 557-575
Open Access | Times Cited: 479
Managing the TME to improve the efficacy of cancer therapy
Maria Teresa Bilotta, Antonella Antignani, David Fitzgerald
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 133
Maria Teresa Bilotta, Antonella Antignani, David Fitzgerald
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 133
Myeloid-derived suppressor cells in cancer and cancer therapy
Samantha Lasser, Feyza Gül Özbay Kurt, Ihor Arkhypov, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 147-164
Closed Access | Times Cited: 132
Samantha Lasser, Feyza Gül Özbay Kurt, Ihor Arkhypov, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 147-164
Closed Access | Times Cited: 132
Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance
Thais Pereira‐Veiga, Svenja Schneegans, Klaus Pantel, et al.
Cell Reports (2022) Vol. 40, Iss. 9, pp. 111298-111298
Open Access | Times Cited: 98
Thais Pereira‐Veiga, Svenja Schneegans, Klaus Pantel, et al.
Cell Reports (2022) Vol. 40, Iss. 9, pp. 111298-111298
Open Access | Times Cited: 98
Formation of pre-metastatic niches induced by tumor extracellular vesicles in lung metastasis
Yuping Liu, Dengxuan Mao, Hong Wang, et al.
Pharmacological Research (2023) Vol. 188, pp. 106669-106669
Open Access | Times Cited: 20
Yuping Liu, Dengxuan Mao, Hong Wang, et al.
Pharmacological Research (2023) Vol. 188, pp. 106669-106669
Open Access | Times Cited: 20
Exosomes and cancer immunotherapy: A review of recent cancer research
Yue Cao, Peng Xu, Yangling Shen, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 18
Yue Cao, Peng Xu, Yangling Shen, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 18
Human NK cells and cancer
Claudia Cantoni, Michela Falco, Massimo Vitale, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Claudia Cantoni, Michela Falco, Massimo Vitale, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Exosome as a crucial communicator between tumor microenvironment and gastric cancer (Review)
Menghui Wang, Hongxin Shu, Xifu Cheng, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 3
Open Access | Times Cited: 6
Menghui Wang, Hongxin Shu, Xifu Cheng, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 3
Open Access | Times Cited: 6
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 789-789
Open Access | Times Cited: 13
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 789-789
Open Access | Times Cited: 13
Tumor microenvironment as niche constructed by cancer stem cells: Breaking the ecosystem to combat cancer
Hao Zhong, Shiyue Zhou, Shuangshuang Yin, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5
Hao Zhong, Shiyue Zhou, Shuangshuang Yin, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5
Dual roles of myeloid-derived suppressor cells in various diseases: a review
Mahesh R. Nepal, S. P. Shah, Kyu‐Tae Kang
Archives of Pharmacal Research (2024) Vol. 47, Iss. 7, pp. 597-616
Closed Access | Times Cited: 5
Mahesh R. Nepal, S. P. Shah, Kyu‐Tae Kang
Archives of Pharmacal Research (2024) Vol. 47, Iss. 7, pp. 597-616
Closed Access | Times Cited: 5
Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance
Yumin Fu, Xinyu Guo, Linmao Sun, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 5
Yumin Fu, Xinyu Guo, Linmao Sun, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 5
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells
Nicola Tumino, Piera Filomena Fiore, Andrea Pelosi, et al.
Seminars in Immunology (2022) Vol. 61-64, pp. 101668-101668
Open Access | Times Cited: 21
Nicola Tumino, Piera Filomena Fiore, Andrea Pelosi, et al.
Seminars in Immunology (2022) Vol. 61-64, pp. 101668-101668
Open Access | Times Cited: 21
Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment
Jennifer H. Cao, Lyndah Chow, Steven Dow
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Jennifer H. Cao, Lyndah Chow, Steven Dow
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
The Role of Neutrophil in COVID-19 — Positive or Negative
Na Rong, Xiaohui Wei, Jiangning Liu
Journal of Innate Immunity (2024)
Open Access | Times Cited: 4
Na Rong, Xiaohui Wei, Jiangning Liu
Journal of Innate Immunity (2024)
Open Access | Times Cited: 4
Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion
Xia Yang, Chunye Huang, Min Zhong, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Xia Yang, Chunye Huang, Min Zhong, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
T cells in the microenvironment of solid pediatric tumors: the case of neuroblastoma
Enrico Maggi, Nadine Landolina, Enrico Munari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Enrico Maggi, Nadine Landolina, Enrico Munari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Myeloid-derived suppressor cells in metabolic and cardiovascular disorders
Jingsheng Yan, Shuai Guo, Jun He, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access
Jingsheng Yan, Shuai Guo, Jun He, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access
Neuroblastoma Tumor-Associated Mesenchymal Stromal Cells Regulate the Cytolytic Functions of NK Cells
Sabina Di Matteo, Maria Antonietta Avanzini, Glória Pelizzo, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 19-19
Open Access | Times Cited: 16
Sabina Di Matteo, Maria Antonietta Avanzini, Glória Pelizzo, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 19-19
Open Access | Times Cited: 16
Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation
Alejandro Castillo-Peña, Sonia Molina‐Pinelo
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Alejandro Castillo-Peña, Sonia Molina‐Pinelo
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
Volker Schirrmacher, Stefaan Van Gool, Wilfried Stuecker
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13050-13050
Open Access | Times Cited: 15
Volker Schirrmacher, Stefaan Van Gool, Wilfried Stuecker
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13050-13050
Open Access | Times Cited: 15
High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth—Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen
Richard E. Kast
Cancers (2022) Vol. 14, Iss. 19, pp. 4965-4965
Open Access | Times Cited: 11
Richard E. Kast
Cancers (2022) Vol. 14, Iss. 19, pp. 4965-4965
Open Access | Times Cited: 11
Causal relationships between immune cell phenotypes and lung adenocarcinoma: A bidirectional two‐sample Mendelian randomization study
Bowen Li, Zhicheng Huang, Yadong Wang, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 21, pp. 1673-1680
Open Access | Times Cited: 1
Bowen Li, Zhicheng Huang, Yadong Wang, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 21, pp. 1673-1680
Open Access | Times Cited: 1
Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions
Mehdi Chaib, Ubaid Tanveer, Liza Makowski
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108370-108370
Open Access | Times Cited: 3
Mehdi Chaib, Ubaid Tanveer, Liza Makowski
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108370-108370
Open Access | Times Cited: 3
Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
Sergi Benavente
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 291-313
Open Access | Times Cited: 3
Sergi Benavente
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 291-313
Open Access | Times Cited: 3